Evidence map›Paper›PMID 36304000›Full record

ReviewFrontiers in reproductive health2021

Genitourinary Syndrome of Menopause: Epidemiology, Physiopathology, Clinical Manifestation and Diagnostic.

Ayane Cristine Alves Sarmento, Ana Paula Ferreira Costa, Pedro Vieira-Baptista, Paulo César Giraldo, José Eleutério, Ana Katherine Gonçalves

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Frontiers in reproductive health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06925139 nacompletednot on this mapstarted 2024, after this paper: background citation

Efficacy of Non-Ablative Radiofrequency on Vaginal and Sexual Health in Postmenopausal Women: a Randomized Clinical Trial

TypeinterventionalSponsorUniversity of Castilla-La ManchaRan2024 to 2024Enrolled62ConditionsGenitourinary Syndrome of Menopause, Vaginal Health, Sexual DysfunctionArmsNon-ablative monopolar radiofrequency treatment
NCT07651566 completednot on this mapstarted 2025, after this paper: background citation

Investigation of the Relationship Between Genitourinary System Symptoms, Respiratory Functions, and Respiratory Muscle Strength in the Postmenopausal Period

Typeobservational_patient_registrySponsorHalic UniversityRan2025 to 2026Enrolled28ConditionsMenopause
3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Efficacy ofNutrients · 2024
    Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ayane Cristine Alves SarmentoPostgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
Ana Paula Ferreira CostaPostgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
Pedro Vieira-BaptistaLower Genital Tract Unit, Centro Hospitalar de São João, Porto, Portugal.
Paulo César GiraldoDepartment of Obstetrics and Gynecology, State University of Campinas, Campinas, Brazil.
José EleutérioDepartment of Obstetrics and Gynecology, Federal University of Ceará, Fortaleza, Brazil.
Ana Katherine GonçalvesPostgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genitourinary syndrome of menopause (GSM) is a term used to define a compilation of signs and symptoms arising from decreased estrogenic stimulation of the vulvovaginal and lower urinary tract. Among 27-84% of women in postmenopausal are affected for symptoms of GSM, and these can unquestionably impair health, sexual function, consequently the quality of life of these women. The main signs and symptoms of GSM include, among others, burning, irritation, vulvovaginal dryness, dyspareunia, urinary symptoms of urgency, dysuria, or recurrent urinary tract infection. The diagnosis can be made through anamnesis, questionnaires, physical exams, and, sometimes, complementary exams. Objective vaginal assessment is essential and can be complemented by using the Vaginal Health Index (VHI), Vaginal Maturation Index (VMI), or vaginal pH measurement. The acknowledgment of this condition by health professionals is crucial for its identification and proper management and exclusion of other conditions that make a differential diagnosis with it.

Indexed as

diagnosisepidemiologygenitourinary syndrome of menopausemenopausevulvovaginal atrophy

Identifiers

PMID36304000
PMCPMC9580828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.